CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Equity	Additional Paid in Capital	Accumulated Other Comprehensive Gain	Accumulated Deficit	Seed Series Redeemable Convertible Preferred Stock	Series B Redeemable Convertible Preferred Stock	Series C Redeemable Convertible Preferred Stock
Beginning balance (in shares) at Dec. 31, 2023						81,790,144	105,595,101	119,599,872
Beginning balance at Dec. 31, 2023						$ 81,525	$ 121,148	$ 164,604
Redeemable Convertible Preferred Stock
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)						(81,790,144)	(105,595,101)	(119,599,872)
Conversion of convertible preferred stock into common stock upon initial public offering						$ (81,525)	$ (121,148)	$ (164,604)
Ending balance (in shares) at Dec. 31, 2024						0	0	0
Ending balance at Dec. 31, 2024						$ 0	$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2023		640,386
Beginning balance at Dec. 31, 2023	$ (148,769)	$ 2	$ 4,250		$ (153,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering cost, expenses and discount (in shares)		20,125,000
Issuance of common stock, net of offering cost, expenses and discount	332,429	$ 2	332,427
Conversion of convertible preferred stock into common stock upon initial public offering (in shares)		33,210,876
Conversion of convertible preferred stock into common stock upon initial public offering	367,153	$ 3	367,150
Issuance of common stock upon exercise of stock options (in shares)		416,555
Issuance of common stock upon exercise of stock options	1,660		1,660
Vesting of restricted common stock (in shares)		47,196
Stock-based compensation	7,397		7,397
Net loss	$ (67,995)				(67,995)
Ending balance (in shares) at Dec. 31, 2024	54,440,013	54,440,013
Ending balance at Dec. 31, 2024	$ 491,875	$ 7	712,884	$ 0	(221,016)
Ending balance (in shares) at Dec. 31, 2025						0	0	0
Ending balance at Dec. 31, 2025						$ 0	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of offering cost, expenses and discount (in shares)		1,604,000
Issuance of common stock, net of offering cost, expenses and discount	$ 29,498		29,498
Issuance of common stock upon exercise of stock options (in shares)	556,711	556,711
Issuance of common stock upon exercise of stock options	$ 2,780		2,780
Stock-based compensation	15,006		15,006
Unrealized gain on marketable securities, net of tax	243			243
Net loss	$ (137,950)				(137,950)
Ending balance (in shares) at Dec. 31, 2025	56,600,724	56,600,724
Ending balance at Dec. 31, 2025	$ 401,452	$ 7	$ 760,168	$ 243	$ (358,966)